Perspective Therapeutics annual operating margin
2016
2017
2018
2019
2020
2021
2022
2023
Perspective Therapeutics Operating Margin Growth & History (CATX)
Perspective Therapeutics's operating margin was −2,855.02% for fiscal 2023.
View full Perspective Therapeutics company overviewPerspective Therapeutics annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2023 | 2023-12-31 | −2,855.02% | −2795.56 pp |
| 2022 | 2022-06-30 | −59.46% | −25.18 pp |
| 2021 | 2021-06-30 | −34.28% | +1.63 pp |
| 2020 | 2020-06-30 | −35.91% | +35.93 pp |
| 2019 | 2019-06-30 | −71.83% | +41.77 pp |
| 2018 | 2018-06-30 | −113.61% | +18.86 pp |
| 2017 | 2017-06-30 | −132.47% | −25.91 pp |
| 2016 | 2016-06-30 | −106.56% | — |
Perspective Therapeutics quarterly operating margin
Q3.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q3.23
Q2.23
Q3.23
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q3 2023 · Sep 30 | 2023-09-30 | −510.74% | −426.67 pp |
| Q2 2023 | 2023-06-30 | −650.27% | −602.98 pp |
| Q3 2023 · Mar 31 | 2023-03-31 | −533.39% | −475.33 pp |
| Q1 2023 | 2022-09-30 | −245.08% | −156.39 pp |
| Q4 2022 | 2022-06-30 | −84.07% | −43.74 pp |
| Q3 2022 | 2022-03-31 | −47.29% | −17.82 pp |
| Q2 2022 | 2021-12-31 | −58.06% | −21.05 pp |
| Q1 2022 | 2021-09-30 | −88.69% | −58.74 pp |
| Q4 2021 | 2021-06-30 | −40.33% | +11.84 pp |
| Q3 2021 | 2021-03-31 | −29.46% | −10.43 pp |
| Q2 2021 | 2020-12-31 | −37.01% | +3.93 pp |
| Q1 2021 | 2020-09-30 | −29.95% | +6.16 pp |
| Q4 2020 | 2020-06-30 | −52.17% | +7.29 pp |
| Q3 2020 | 2020-03-31 | −19.03% | +41.42 pp |
| Q2 2020 | 2019-12-31 | −40.93% | +34.12 pp |
| Q1 2020 | 2019-09-30 | −36.11% | +61.07 pp |
| Q4 2019 | 2019-06-30 | −59.46% | +88.39 pp |
| Q3 2019 | 2019-03-31 | −60.45% | +24.68 pp |
| Q2 2019 | 2018-12-31 | −75.05% | +20.52 pp |
| Q1 2019 | 2018-09-30 | −97.18% | +30.98 pp |
| Q4 2018 | 2018-06-30 | −147.85% | −39.50 pp |
| Q3 2018 | 2018-03-31 | −85.12% | — |
| Q2 2018 | 2017-12-31 | −95.57% | — |
| Q1 2018 | 2017-09-30 | −128.16% | — |
| Q3 2017 | 2017-03-31 | −108.35% | — |
Perspective Therapeutics operating margin trends
Over the last five reported fiscal years, Perspective Therapeutics's operating margin decreased from −113.61% to −2,855.02%, a change of −2741.41 percentage points. The latest reported quarter, Q3 2023 · Sep 30, shows −510.74%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Perspective Therapeutics filings at SEC.gov ↗